The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
APOGEE THERAPEUTICS INC COM 03770N101 7,788,065 58,676 SH SOLE 0 58,676 0 0
AVANOS MED INC COM 05350V106 3,857,793 155,056 SH SOLE 0 155,056 0 0
ESPERION THERAPEUTICS INC NE COM 29664W105 14,003,850 4,431,598 SH SOLE 0 4,431,598 0 0
JANUS HENDERSON GROUP PLC ORD SHS G4474Y214 73,528,000 1,414,000 SH SOLE 0 1,414,000 0 0
SILA REALTY TRUST INC COMMON STOCK 146280508 6,072,000 200,000 SH SOLE 0 200,000 0 0
TAYLOR MORRISON HOME CORP COM 87724P106 3,587,000 50,000 SH SOLE 0 50,000 0 0
TD SYNNEX CORPORATION COM 87162W100 1,832,081 6,853 SH SOLE 0 6,853 0 0